Oral decongestants flagged for cardiovascular risk in elderly
Key Questions
What cardiovascular risks are associated with oral decongestants?
Pseudoephedrine (pseudo), phenylephrine (PE), ephedrine, and phenylpropanolamine (PPA) in products like Theraflu, Comtrex, and Dallergy raise blood pressure, stroke, arrhythmia, and hyperglycemia risks, especially in the elderly.
Who is most at risk from these decongestants?
Elderly women over 70 with hypertension, metoprolol, enalapril, captopril, midodrine, CAD, diabetes, or caffeine use face heightened emergency risks.
What interactions occur with blood pressure medications?
Enalapril + ibuprofen/PE and captopril + Theraflu Nighttime show kidney damage intensification and 52-65 potential interactions affecting BP control.
How do decongestants interact with diabetes drugs?
Products like Alka-Seltzer Plus with alogliptin or Night Time Severe Cold with miglitol have 40+ interactions, worsening hyperglycemia.
What role does a cardiac surgeon play in these warnings?
Dr. Michael Grant warns that certain drugs, including decongestants, damage hearts in older adults, linking to rising ER visits.
Are there interactions with antidepressants like Zoloft?
Vicks NyQuil Severe with Zoloft has 58 interactions, increasing arrhythmia and CNS risks.
What about interactions with other cold products?
Dallergy PSE with Night Time Multi Symptom or Comtrex Sinus with Lorcet Plus show multiple interactions, compounding CV risks.
How does midodrine interact with decongestants?
Hydroxy Compound (decongestant) with midodrine has 67 interactions, severely elevating BP and stroke risks.
Pseudo/PE/ephedrine/PPA (Theraflu/Comtrex/Dallergy) BP/stroke/arrhythmia/hyperglycemia ER w/metoprolol/HTN/enalapril/captopril/midodrine/CAD/diabetes/caffeine esp women 70+. Enalapril+ibuprofen/PE kidney flags intensify.